Uniklinik Köln (CIO)
Uniklinik Köln runs the Centre for Integrated Oncology and leads lung cancer genomics via the Network Genomic Medicine.
Network Genomic Medicine Lung Cancer (Wolf, Thomas) sequenced tens of thousands of NSCLC patients; CLL leadership (Hallek, German CLL Study Group).
- Lung cancer genomics
- CLL
Built the Network Genomic Medicine that brought molecular testing to lung cancer patients across Germany, and led the capmatinib GEOMETRY trial.
Leads the German CLL Study Group, whose trials (CLL8, CLL14, CLL13) set global standards for CLL treatment.
Molecular pathologist who co-founded Network Genomic Medicine and characterised lung cancer genomes.
Roman Thomas is a cancer genomicist who mapped the genomes of small-cell lung cancer.
Pages like this
not linked directly; found by shared links- ProductCapmatinib & tepotinib
Shares Jürgen Wolf, Non-small-cell lung cancer.
- TrialCLL14
- TrialCLL13 / GAIA
- InstitutionEuropean Hematology Association
- Key paperCLL14: one year of venetoclax plus obinutuzumab instead of chemo-immunotherapy in older, less fit CLL patients
- InstitutionHeidelberg University Hospital / NCT / DKFZ
Shares Deutsche Krebshilfe, University Hospital Düsseldorf / CIO Düsseldorf.
- ProductObinutuzumab
- InstitutionBarts Cancer Institute / Barts Health NHS Trust
Shares Chronic lymphocytic leukaemia, Non-small-cell lung cancer.